Urinary Cancer

Original Article

A patient-derived bladder cancer organoid and xenograft platform for personalized drug response prediction and salvage therapeutics screening
Junlin Lu,Kaiwen Jie,Chu Liu,Jiajian Lai,Peng Xu,Xinxin He,Kanghua Xiao,Yating Chen,Sen Liu,Zehua Chen,Jianhui Zhang,Zegeng Yang,Shizhi Lin,Qiang Zhang,Ming Huang,Liang Cheng,Siting Chen,Jianmei Zhong,Sheng Li,Hong Li,Xu Chen
Olaparib delays resolution of irreversible electroporation-induced DNA damage and enhances short-term antitumor activity in prostate cancer models
Jiacheng Xiang,Zhiyu Xia,Yuan Wang,Shaogang Wang,Qidong Xia
Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway
Zhipeng Wang,Jie Wang,Shuang Chen,Ruicheng Wu,Zhouting Tuo,Luxia Ye,Koo Han Yoo,Dengxiong Li,Xiaodong Jin,Wei Xiong,Dechao Feng
Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer
Facai Zhang,Yunkai Yang,Rong Zhang,Huan Hu,Chuanzan Zhou,Jie Wang,Ruicheng Wu,Enhui Li,William C. Cho,Dahong Zhang,Qi Zhang,Dechao Feng
Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers
Na Zeng,Guichen Ye,Mengchu Zheng,Guangyuan Liu,Sihan Zhang,Siyang Ma,Zhiyu Xia,Yirong Zhou,Shaogang Wang,Qidong Xia
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer
Tao Ding,Lina He,Guowen Lin,Lei Xu,Yanjun Zhu,Xinan Wang,Xuefei Liu,Jianming Guo,Fanghong Lei,Zhixiang Zuo,Jianghua Zheng